Overview

A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria

Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to explore the onset of action when serotonin reuptake inhibitors are used to treat premenstrual dysphoric disorder
Phase:
Phase 4
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
GlaxoSmithKline
Göteborg University
Novo Nordisk A/S
Treatments:
Paroxetine